Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Aytu Biopharma (AYTU) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Aytu Biopharma (AYTU) over the last 6 years, with Q2 2025 value amounting to $652000.0.

  • Aytu Biopharma's Tax Provisions fell 2247.32% to $652000.0 in Q2 2025 from the same period last year, while for Dec 2025 it was $530000.0, marking a year-over-year decrease of 6387.18%. This contributed to the annual value of $652000.0 for FY2025, which is 6956.12% down from last year.
  • Aytu Biopharma's Tax Provisions amounted to $652000.0 in Q2 2025, which was down 2247.32% from -$122000.0 recorded in Q1 2025.
  • Over the past 5 years, Aytu Biopharma's Tax Provisions peaked at $841000.0 during Q2 2024, and registered a low of -$300000.0 during Q4 2024.
  • Over the past 4 years, Aytu Biopharma's median Tax Provisions value was $265500.0 (recorded in 2023), while the average stood at $281300.0.
  • Examining YoY changes over the last 5 years, Aytu Biopharma's Tax Provisions showed a top increase of 56746.03% in 2024 and a maximum decrease of 13750.0% in 2024.
  • Aytu Biopharma's Tax Provisions (Quarter) stood at -$3000.0 in 2021, then surged by 26766.67% to $800000.0 in 2023, then plummeted by 137.5% to -$300000.0 in 2024, then skyrocketed by 317.33% to $652000.0 in 2025.
  • Its Tax Provisions was $652000.0 in Q2 2025, compared to -$122000.0 in Q1 2025 and -$300000.0 in Q4 2024.